Category: COVID19 Vaccines T Cells
Thursday, January 21, 2021
Although it may be too early to say, some scientists suggest the answer is yes. In a recent editorial in a vaccine focused medical journal, some argue that the time is ripe for a “T-cell focused approach” to vaccine development. Historically, vaccine development focuses on antibody production (B-cells) against viruses, but overwhelming research on the human immune response to SARS-CoV2 points to T-cell function as the main driver of lasting immunity.
at Thursday, January 21, 2021